Max Robotics — Global Service Robot Directory + US Certification

About

Alec Zhu is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes and healthcare delivery in robotic-assisted urologic oncology. His primary research areas include same-day discharge protocols, cost-effectiveness analyses, and comparative effectiveness of treatments for prostate and kidney cancers. Zhu’s landmark 2023 study on same-day discharge versus inpatient robotic-assisted radical prostatectomy (28 citations) demonstrated that outpatient surgery can achieve comparable complication rates while significantly reducing costs and maintaining high patient satisfaction—a finding accelerated by the COVID-19 pandemic. He has also advanced nerve-sparing techniques during robot-assisted radical prostatectomy, notably through clipless approaches that improve functional outcomes. His comparative effectiveness research on partial gland cryoablation versus robotic radical prostatectomy (10 citations) provides critical evidence for treatment selection. Zhu’s multi-center analysis on age-related outcomes (5 citations) further personalizes surgical decision-making. Beyond clinical innovation, he has investigated national trends in hemostatic agent use and the economics of robotic versus laparoscopic nephrectomy, highlighting cost drivers in major urologic surgery. His pioneering work on outpatient robotic retroperitoneal lymph node dissection represents a paradigm shift in testicular cancer management. With over 65 total citations, Zhu is shaping the future of value-based, patient-centered urologic care.